CD19 and systemic sclerosis: Flow cytometry of blood samples from 76 SSc patients and 59 healthy controls demonstrated an increased expression of the inhibitory receptor FcγRIIB levels on naïve (CD19+IgD+CD27+) and double-negative (DN) CD19+IgD−CD27− memory B cells in SSc patients compared to controls (12).